Evolent Health (EVH) Receivables (2015 - 2026)

Evolent Health's Receivables history runs 12 years deep, the most recent figure standing at $315.0 million for Q1 2026.

• In Q1 2026, Receivables fell 28.52% year-over-year to $315.0 million; the TTM figure through Mar 2026 stood at $315.0 million (down 28.52% YoY), while the FY2025 annual figure was $311.0 million, down 26.12% from the prior year.
• Receivables was $315.0 million for Q1 2026 at Evolent Health, up from $311.0 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $472.4 billion in Q4 2023 to a low of $127.7 million in Q2 2022.
• Historically, Receivables has averaged $28.1 billion across 5 years, with a median of $366.2 million in 2023.
• The sharpest annual moves came in 2023 and 2024: Receivables soared 175429.54% in 2023, then plunged 99.91% in 2024.
• A 5-year view of Receivables shows it stood at $269.1 million in 2022, then jumped by 175429.54% to $472.4 billion in 2023, then slumped by 99.91% to $420.9 million in 2024, then retreated by 26.12% to $311.0 million in 2025, then rose by 1.31% to $315.0 million in 2026.
• The last three Receivables figures came in at $315.0 million (Q1 2026), $311.0 million (Q4 2025), and $408.1 million (Q3 2025), per Business Quant data.